1.Anderson, RM.May, RM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press, 1991.
2.Hairston, NG. On the mathematical analysis of schistosome populations. Bull WHO 1965; 33: 45–62.
3.Macdonald, G. The dynamics of helminth infections, with special reference to schistosomes. Trans Roy Soc Trop Med Hyg 1965; 59: 489–506.
4.Anderson, RM. The dynamics and control of direct life cycle helminth parasites. Lect Notes Biomath 1980; 39: 278–322.
5.Anderson, RM, May, RM. Population dynamics of human helminth infections: control by chemotherapy. Nature 1982; 297: 557–63.
6.Anderson, RM.May, RM. Helminth infections of humans: mathematical models, population dynamics and control. Adv Parasitol 1985; 24: 1–101.
7.Medley, GF.Guyatt, HL.Bundy, DAP. A qualitative framework for evaluating the effect of community treatment on the morbidity due to ascariasis. Parasitology 1993; 106: 211–21.
8.Chan, MS.Guyatt, HL.Bundy, DAP.Medley, GF. The development and validation of an age-structured model for the evaluation of disease control strategies for intestinal helminths. Parasitology 1994; 109: 389–96.
9.Guyatt, HL.Chan, MS.Medley, GF, Bundy, DAP. Control of ascaris infection by chemotherapy: which is the most cost-effective option? Trans Roy Soc Trop Med Hyg 1995; 89: 16–20.
10.Jordan, P. Schistosomiasis: the St Lucia project. Cambridge: Cambridge University Press. 1985.
11.Bundy, DAP. Population ecology of intestinal helminth infections in human communities. Phil Trans Roy Soc Lond 1988; B321: 405–20.
12.Cheever, AW. A quantitative post-mortem study of Schistosomiasis mansoni in man. Am J Trop Med Hyg 1968; 17: 38–64.
13.Guyatt, HL, Bundy, DAP. Estimating prevalence of community morbidity due to intestinal helminths: prevalence of infection as an indicator of the prevalence of disease. Trans Roy Soc Trop Med Hyg 1991; 85: 778–82.
14.Booth, M. The epidemiology and population biology of multiple infections with Ascaris lumbricoides, Trichuris trichiura and hookworms [thesis]. London: University of London. 1994.
15.Butterworth, AE.Sturrock, RF.Ouma, JH et al. Comparison of different chemotherapy strategies against Schistosoma mansoni in Machakos District. Kenya: effects on human infection and morbidity. Parasitology 1991; 103: 339–55.
16.Sturrock, RF.Bensted-Smith, R, Butterworth, AE et al. Immunity after treatment of human Schistosomiasis mansoni. III. Long-term effects of treatment and retreatment. Trans Roy Soc Trop Med Hyg 1987; 81: 303–14.
17.Warren, KS, Bundy, DAP.Anderson, RM et al. Helminth infections. In: Jamison, DT.Mosley, WH.Measham, AR.Bobadilla, JL. eds. Disease control priorities in developing countries. Oxford: Oxford University Press. 1993.
18.Medley, G.Anderson, RM. Density-dependent fecundity in Schistosoma mansoni infections in man. Trans Roy Soc Trop Med Hyg 1985; 79: 532–4.
19.Quinnell, RJ.Medley, GR.Keymer, AE. The regulation of gastrointestinal helminth populations. Phil Trans Roy Soc Lond B 1990; 330: 191–201.
20.de Vlas, SJ.Gryseels, B.van Oortmarssen, GJ.Polderman, AM.Habbema, JDF. A model for variations in single and repeated egg counts in Schistosoma mansoni infections. Parasitology 1990; 104: 451–9.
21.Maizels, RM.Bundy, DAP.Selkirk, ME.Smith, DF.Anderson, RM. Immunological modulation and evasion by helminth parasites in human populations. Nature 1993; 365: 797–805.
22.Smithers, SR.Terry, RJ. Immunity in Schistosomiasis. Ann New York Acad Sci 1969; 160: 826.
23.Muller, R. Worms and disease: a manual of medical lielminthology. London: William Heinemann. 1975.
24.Woolhouse, MEJ. A theoretical framework for the immunoepidemiology of human helminth infection. Parasitol Immunol 1992; 14: 563–78.
25.Numerical Algorithms Group Limited. The NAG Fortran Library. Mark 14. Oxford: NAG. 1990.